{"transactions":[{"id":1258919,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":83036,"kind":"person","name":"Kristal Robert Eugene","position":1,"cik":"0001893955","reported_name":"Kristal Robert Eugene","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2025-02-19T21:26:47.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":166492,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests and becomes exercisable to the extent of 83,246 shares on February 14, 2025 with the remaining 83,246 shares vesting in eight nearly-equal quarterly installments beginning on February 14, 2026 and continuing every three months thereafter until fully vested."}],"balance_after":166492,"derivative":{"exercise_price":2.46,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":166492},"source":{"system":"sec-edgar","filing":"0001021771-25-000040","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177125000040/form4.xml","form_type":"4"}},{"id":1640655,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":83036,"kind":"person","name":"Kristal Robert Eugene","position":1,"cik":"0001893955","reported_name":"Kristal Robert Eugene","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2024-02-15T21:17:05.000Z","date":"2024-02-13","kind":"grant","planned":false,"acquired":true,"shares":263158,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests and becomes exercisable to the extent of 131,579 shares on February 13, 2024 with the remaining 131,579 shares vesting in eight nearly-equal quarterly installments beginning on February 13, 2025 and continuing every three months thereafter until fully vested."}],"balance_after":263158,"derivative":{"exercise_price":1.45,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":263158},"source":{"system":"sec-edgar","filing":"0001021771-24-000048","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000102177124000048/form4.xml","form_type":"4"}},{"id":2006689,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":83036,"kind":"person","name":"Kristal Robert Eugene","position":1,"cik":"0001893955","reported_name":"Kristal Robert Eugene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2023-02-17T22:32:00.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":88968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable to the extent of 44,484 shares on February 17, 2023 with the remaining 44,484 shares vesting in eight nearly-equal quarterly installments beginning on February 17, 2024 and continuing every three months thereafter until fully vested."}],"balance_after":88968,"derivative":{"exercise_price":2.91,"expiration_date":"2033-02-17","underlying":"Common Stock","underlying_shares":88968},"source":{"system":"sec-edgar","filing":"0001567619-23-003328","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761923003328/doc1.xml","form_type":"4"}},{"id":2124216,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":83036,"kind":"person","name":"Kristal Robert Eugene","position":1,"cik":"0001893955","reported_name":"Kristal Robert Eugene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2022-11-04T20:24:32.000Z","date":"2022-11-03","kind":"grant","acquired":true,"shares":10490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested."}],"balance_after":10490,"derivative":{"exercise_price":5.08,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":10490},"source":{"system":"sec-edgar","filing":"0001567619-22-019195","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019195/doc1.xml","form_type":"4"}},{"id":2124215,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":83036,"kind":"person","name":"Kristal Robert Eugene","position":1,"cik":"0001893955","reported_name":"Kristal Robert Eugene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2022-11-04T20:24:32.000Z","date":"2022-11-03","kind":"disposition_to_issuer","acquired":false,"shares":10490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported transactions involved an amendment of an outstanding stock option, resulting in the deemed cancellation of the \"old\" stock option and the grant of a \"replacement\" stock option with a reduced exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":13.5,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":10490},"source":{"system":"sec-edgar","filing":"0001567619-22-019195","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922019195/doc1.xml","form_type":"4"}},{"id":2231175,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":83036,"kind":"person","name":"Kristal Robert Eugene","position":1,"cik":"0001893955","reported_name":"Kristal Robert Eugene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-15T21:50:12.000Z","date":"2022-06-15","kind":"purchase","acquired":true,"shares":194,"price":3.61,"value":700.34,"ownership":{"direct":true},"balance_after":7994,"source":{"system":"sec-edgar","filing":"0001567619-22-012912","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922012912/doc1.xml","form_type":"4"}},{"id":2239961,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":83036,"kind":"person","name":"Kristal Robert Eugene","position":1,"cik":"0001893955","reported_name":"Kristal Robert Eugene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-07T16:22:14.000Z","date":"2022-06-07","kind":"purchase","acquired":true,"shares":200,"price":4.56,"value":912.0,"ownership":{"direct":true},"balance_after":7800,"source":{"system":"sec-edgar","filing":"0001567619-22-012416","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922012416/doc1.xml","form_type":"4"}},{"id":2299231,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":83036,"kind":"person","name":"Kristal Robert Eugene","position":1,"cik":"0001893955","reported_name":"Kristal Robert Eugene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-04-11T14:47:15.000Z","date":"2022-04-08","kind":"purchase","acquired":true,"shares":7600,"price":5.71,"value":43396.0,"ownership":{"direct":true},"balance_after":7600,"source":{"system":"sec-edgar","filing":"0001567619-22-008332","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761922008332/doc1.xml","form_type":"4"}},{"id":2510090,"issuer":{"id":8277,"kind":"organization","name":"BioRestorative Therapies, Inc."},"owners":[{"id":83036,"kind":"person","name":"Kristal Robert Eugene","position":1,"cik":"0001893955","reported_name":"Kristal Robert Eugene","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option","published_at":"2021-11-16T21:24:38.000Z","date":"2021-11-04","kind":"grant","acquired":true,"shares":10490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested."}],"balance_after":10490,"derivative":{"exercise_price":13.5,"expiration_date":"2031-11-04","underlying":"Common Stock","underlying_shares":10490},"source":{"system":"sec-edgar","filing":"0001567619-21-020581","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1505497/000156761921020581/doc1.xml","form_type":"4"}}]}